Breakthrough First-in-Class Covalent Werner Helicase Inhibitor Demonstrates Clinical Proof-of-Concept in Phase I Trial
In a landmark development in the field of oncology and targeted cancer therapies, researchers at The University of Texas MD ...
In a landmark development in the field of oncology and targeted cancer therapies, researchers at The University of Texas MD ...
Cambridge, MA, March 3, 2025 — In a groundbreaking partnership, Insilico Medicine, an innovative player in the biotechnology sector utilizing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine